TY - JOUR
T1 - High-resolution, volumetric diffusion-weighted MR spectroscopic imaging of the brain
AU - Wang, Zepeng
AU - Sutton, Bradley P.
AU - Lam, Fan
N1 - This work was supported in part by NSF\u2010CBET\u20101944249 and NIH\u2010NIBIB\u20101R21EB029076.
PY - 2025/3/10
Y1 - 2025/3/10
N2 - Purpose: To achieve high-resolution, three-dimensional (3D) quantitative diffusion-weighted MR spectroscopic imaging (DW-MRSI) for molecule-specific microstructural imaging of the brain. Methods: We introduced and integrated several innovative acquisition and processing strategies for DW-MRSI: (a) a new double-spin-echo sequence combining selective excitation, bipolar diffusion encoding, rapid spatiospectral sampling, interleaved water spectroscopic imaging data, and a special sparsely sampled echo-volume-imaging (EVI)-based navigator, (b) a rank-constrained time-resolved reconstruction from the EVI data to capture spatially varying phases, (c) a model-based phase correction for DW-MRSI data, and (d) a multi-b-value subspace-based method for water/lipids removal and spatiospectral reconstruction using learned metabolite subspaces, and e) a hybrid subspace and parametric model-based parameter estimation strategy. Phantom and in vivo experiments were performed to validate the proposed method and demonstrate its ability to map metabolite-specific diffusion parameters in 3D. Results: The proposed method generated reproducible metabolite diffusion coefficient estimates, consistent with those from a standard single-voxel DW spectroscopy (SV-DWS) method. High-SNR multi-molecular mean diffusivity (MD) maps can be obtained at a 6.9 (Formula presented.) 6.9 (Formula presented.) 7.0 mm (Formula presented.) nominal resolution with large 3D brain coverage. High-resolution (4.4 (Formula presented.) 4.4 (Formula presented.) 5.6 mm (Formula presented.)) metabolite and diffusion coefficient maps can be obtained within 20 mins for the first time. Tissue-dependent metabolite MDs were observed, i.e., larger MDs for NAA, creatine, and choline in white matter than gray matter, with region-specific differences. Conclusion: We demonstrated an unprecedented capability of simultaneous, high-resolution metabolite and diffusion parameter mapping. This imaging capability has strong potential to offer richer molecular and tissue-compartment-specific microstructural information for various clinical and neuroscience applications.
AB - Purpose: To achieve high-resolution, three-dimensional (3D) quantitative diffusion-weighted MR spectroscopic imaging (DW-MRSI) for molecule-specific microstructural imaging of the brain. Methods: We introduced and integrated several innovative acquisition and processing strategies for DW-MRSI: (a) a new double-spin-echo sequence combining selective excitation, bipolar diffusion encoding, rapid spatiospectral sampling, interleaved water spectroscopic imaging data, and a special sparsely sampled echo-volume-imaging (EVI)-based navigator, (b) a rank-constrained time-resolved reconstruction from the EVI data to capture spatially varying phases, (c) a model-based phase correction for DW-MRSI data, and (d) a multi-b-value subspace-based method for water/lipids removal and spatiospectral reconstruction using learned metabolite subspaces, and e) a hybrid subspace and parametric model-based parameter estimation strategy. Phantom and in vivo experiments were performed to validate the proposed method and demonstrate its ability to map metabolite-specific diffusion parameters in 3D. Results: The proposed method generated reproducible metabolite diffusion coefficient estimates, consistent with those from a standard single-voxel DW spectroscopy (SV-DWS) method. High-SNR multi-molecular mean diffusivity (MD) maps can be obtained at a 6.9 (Formula presented.) 6.9 (Formula presented.) 7.0 mm (Formula presented.) nominal resolution with large 3D brain coverage. High-resolution (4.4 (Formula presented.) 4.4 (Formula presented.) 5.6 mm (Formula presented.)) metabolite and diffusion coefficient maps can be obtained within 20 mins for the first time. Tissue-dependent metabolite MDs were observed, i.e., larger MDs for NAA, creatine, and choline in white matter than gray matter, with region-specific differences. Conclusion: We demonstrated an unprecedented capability of simultaneous, high-resolution metabolite and diffusion parameter mapping. This imaging capability has strong potential to offer richer molecular and tissue-compartment-specific microstructural information for various clinical and neuroscience applications.
KW - DW-MRSI
KW - MRSI
KW - microstructural imaging
KW - neuroimaging
KW - quantitative imaging
KW - subspace imaging
UR - http://www.scopus.com/inward/record.url?scp=105000144966&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=105000144966&partnerID=8YFLogxK
U2 - 10.1002/mrm.30479
DO - 10.1002/mrm.30479
M3 - Article
C2 - 40065541
AN - SCOPUS:105000144966
SN - 0740-3194
VL - 94
SP - 450
EP - 469
JO - Magnetic Resonance in Medicine
JF - Magnetic Resonance in Medicine
IS - 2
ER -